Skip to main content Accessibility help

A nonsense variation p.Arg325X in the vascular endothelial growth factor-A gene may be associated with congenital tricuspid aortic valve stenosis

  • Wu Zhao (a1) (a2), Jian Wang (a3), Jie Shen (a4), Kun Sun (a5), Yiwei Chen (a1), Wei Ji (a1), Lijun Fu (a1), Yurong Wu (a1) and Fen Li (a1)...



In our recent study, we first reported that mutation in vascular endothelial growth factor-A is associated with bicuspid aortic valve stenosis. However, to date no groups have explored the role of vascular endothelial growth factor-A variations in the aetiology of congenital tricuspid aortic valve stenosis.


We sequenced all eight coding exons and exon–intron boundaries of the vascular endothelial growth factor-A gene in deoxyribonucleic acid samples of a cohort of 32 sporadic patients with tricuspid aortic valve stenosis, 300 normal controls, and 103 disease controls – conotruncal defects – in order to identify sequence variants.


We identified a c.973C > T heterozygous nonsense variation in exon 6 of the vascular endothelial growth factor-A gene in a patient with an isolated tricuspid aortic valve stenosis. The c.973C > T variation, which was absent in all controls, changes a highly conserved arginine at amino acid position 325 to a stop codon (p.Arg325X) and is predicted to produce a truncated protein of 324 amino acid residues. The proband's parents had a normal cardiac phenotype; however, his father was a carrier of the p.Arg325X variation, which indicates that the p.Arg325X variation is inherited and incompletely penetrant.


We report for the first time that the p.Arg325X nonsense variation in the vascular endothelial growth factor-A gene may be associated with congenital tricuspid aortic valve stenosis.


Corresponding author

Correspondence to: Dr F. Li, Department of Cardiology, Shanghai Children's Medical Center, Shanghai Jiaotong University School of Medicine, Shanghai 200127, People's Republic of China. Tel: +86 21 38626161; Fax: +86 21 58393915; E-mail:


Hide All
1.St Louis, JD, Jaggers, J. Left ventricular outflow tract obstruction. In: Nichols DG, Ungerleider RM, Spevak PJ (eds.). Critical Heart Disease in Infants and Children, 2nd edn. Mosby, Philadelphia, 2006, pp 609623.
2.Mack, G, Silberbach, M. Aortic and pulmonary stenosis. Pediatr Rev 2000; 21: 7985.
3.Reich, O. Aortic valve, congenital stenosis. In: Sievert H, Qureshi SA, Wilson N, Hijazi ZM (eds.). Percutaneous Interventions for Congenital Heart disease. Informa Healthcare, London, 2007, pp 153162.
4.Roberts, WC, Ko, JM. Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation. Circulation 2005; 111: 920925.
5.Godden, DJ, Sandhu, PS, Kerr, F. Stenosed bicuspid aortic valves in twins. Eur Heart J 1987; 8: 316318.
6.McDonald, K, Maurer, BJ. Familial aortic valve disease: evidence for a genetic influence? Eur Heart J 1989; 10: 676677.
7.McBride, KL, Riley, MF, Zender, GA, et al. NOTCH1 mutations in individuals with left ventricular outflow tract malformations reduce ligand-induced signaling. Hum Mol Genet 2008; 17: 28862893.
8.Zhao, W, Wang, J, Shen, J, et al. Mutations in VEGFA are associated with congenital left ventricular outflow tract obstruction. Biochem Biophys Res Commun 2010; 396: 483488.
9.Armstrong, EJ, Bischoff, J. Heart valve development: endothelial cell signaling and differentiation. Circ Res 2004; 95: 459470.
10.Wagner, M, Siddiqui, MA. Signal transduction in early heart development (II): ventricular chamber specification, trabeculation, and heart valve formation. Exp Biol Med (Maywood) 2007; 232: 866880.
11.Nguyen, KH. Congenital heart surgery nomenclature and database project: aortic valve disease. Ann Thorac Surg 2000; 69: S118S131.
12.Griffin, HR, Hall, DH, Topf, A, et al. Genetic variation in VEGF does not contribute significantly to the risk of congenital cardiovascular malformation. PLoS One 2009; 4: e4978.
13.Huez, I, Bornes, S, Bresson, D, Créancier, L, Prats, H. New vascular endothelial growth factor isoform generated by internal ribosome entry site-driven CUG translation initiation. Mol Endocrinol 2001; 15: 21972210.
14.Meiron, M, Anunu, R, Scheinman, EJ, Hashmueli, S, Levi, BZ. New isoforms of VEGF are translated from alternative initiation CUG codons located in its 5′UTR. Biochem Biophys Res Commun 2001; 282: 10531060.
15.Tee, MK, Jaffe, RB. A precursor form of vascular endothelial growth factor arises by initiation from an upstream in-frame CUG codon. Biochem J 2001; 359: 219226.
16.Dowlati, A. Hunting and trapping the vascular endothelial growth factor. J Clin Oncol 2010; 28: 185187.
17.Ribeiro, LA, Bacci, ML, Seren, E, Tamanini, C, Forni, M. Characterization and differential expression of vascular endothelial growth factor isoforms and receptors in swine corpus luteum throughout estrous cycle. Mol Reprod Dev 2007; 74: 163171.
18.Tischer, E, Mitchell, R, Hartman, T, et al. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 1991; 266: 1194711954.
19.Poltorak, Z, Cohen, T, Sivan, R, et al. VEGF145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix. J Biol Chem 1997; 272: 71517158.
20.Whittle, C, Gillespie, K, Harrison, R, Mathieson, PW, Harper, SJ. Heterogeneous vascular endothelial growth factor (VEGF) isoform mRNA and receptor mRNA expression in human glomeruli, and the identification of VEGF148 mRNA, a novel truncated splice variant. Clin Sci (Lond) 1999; 97: 303312.
21.Bates, DO, Cui, TG, Doughty, JM, et al. VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma. Cancer Res 2002; 62: 41234131.
22.Lei, J, Jiang, A, Pei, D. Identification and characterization of a new splicing variant of vascular endothelial growth factor: VEGF183. Biochim Biophys Acta 1998; 1443: 400406.
23.Houck, KA, Ferrara, N, Winer, J, Cachianes, G, Li, B, Leung, DW. The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 1991; 5: 18061814.
24.Nicholson, P, Yepiskoposyan, H, Metze, S, Zamudio Orozco, R, Kleinschmidt, N, Mühlemann, O. Nonsense-mediated mRNA decay in human cells: mechanistic insights, functions beyond quality control and the double-life of NMD factors. Cell Mol Life Sci 2010; 67: 677700.



Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed